In fact, the most prominent CAD risk locus at Chr9p21 (66, 67) harbors the lncRNA—ANRIL (Antisense Non-coding RNA in the INK4 Locus, CDKN2B antisense RNA). This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.